Variants in the Mitochondrial Intermediate Peptidase (MIPEP) Gene are Associated with Gray Matter Density in the Alzheimer’s Disease Neuroimaging Initiative Cohort by Nudelman, Kelly N. H. et al.
Variants in the Mitochondrial Intermediate Peptidase (MIPEP) Gene are 
Associated with Gray Matter Density in the Alzheimer’s Disease Neuroimaging 
Initiative Cohort 
Kelly N. H. Nudelman1,2, Shannon L. Risacher2,3, John D. West2,3, Brenna C. 
McDonald2,3,4, Su Gao3,5, Andrew J. Saykin1,2,3,4, for the Alzheimer’s Disease 
Neuroimaging Initiative 
1Department of Medical and Molecular Genetics, Indiana University School of Medicine (IUSM), 
Indianapolis, IN; 2Center for Neuroimaging, Department of Radiology and Imaging Sciences, IUSM, 
Indianapolis, IN; 3Indiana Alzheimer’s Disease Center, IUSM, Indianapolis, IN; 4IU Melvin and Bren Simon 
Cancer Center, IUSM, Indianapolis, IN; 5Department of Biostatistics, IUSM, Indianapolis, IN  
Cancer and Alzheimer’s disease (AD) incidence is inversely correlated, but the 
genetic underpinnings of this relationship remain to be elucidated. Recent findings 
identified lower gray matter density in frontal regions of participants of the Alzheimer’s 
Disease Neuroimaging Initiative (ADNI) with cancer history compared to those without 
such history, across diagnostic groups (Nudelman et al., 2014). Pathways proposed to 
impact cancer and AD, including metabolism and survival, may play an important role in 
the observed difference. To test this hypothesis, a genome-wide association study 
(GWAS) using mean frontal gray matter cluster values was performed for all Caucasian 
participants in this cohort with neuroimaging and genetic data (n=1405). Analysis 
covaried for age, sex, AD, and cancer history. Of the two genes with the most significant 
SNPs (p<10-5), WD repeat domain 5B (WDR5B) and mitochondrial intermediate 
peptidase (MIPEP), MIPEP was selected for further analysis given the hypothesis focus 
on metabolism. ANOVA analysis of MIPEP top SNP rs8181878 with frontal gray matter 
cluster values in SPSS indicated that while this SNP is significantly associated with gray 
matter density (p=2x10-6), no interaction was observed with cancer history or AD 
diagnosis. Furthermore, whole brain gray matter voxel-wise analysis of this SNP using 
Statistical Parametric Mapping 8 software showed that minor allele(s) of this SNP were 
significantly (PFWE<0.05) associated with higher gray matter density. These results 
suggest that the minor allele of MIPEP SNP rs8181878 may be protective against gray 
matter density loss, highlighting the importance of metabolic processes in aging and 
disease. 
